Table 4.
Multivariate rank-based estimation regression models for relative change (%/year) in thoracic atherosclerotic plaque volume from baseline to follow-up (Scan 0–Scan 1)
| Non-calcified plaque volume | Calcified plaque volume | |||
| Beta | P value | Beta | P value | |
| ICI use | 7.9 | 0.015 | −20.7 | 0.022 |
| Age | −0.2 | 0.20 | 0.3 | 0.59 |
| Female | 3.4 | 0.24 | 1.9 | 0.81 |
| Diabetes | −0.2 | 0.96 | −7.5 | 0.52 |
| Hyperlipidemia | 8.5 | 0.043 | 19.1 | 0.10 |
| Hypertension | 5.9 | 0.071 | 6.7 | 0.46 |
| Statin | −7.3 | 0.10 | 0.6 | 0.96 |
| History of smoking | −3.5 | 0.28 | −3.1 | 0.73 |
| Prior radiation | −7.6 | 0.12 | 1.5 | 0.92 |
ICI, immune checkpoint inhibitor.